It has been discovered that some of these genes (C2, BX511262.2, PRRC2A, BAG6, PBX2, GPSM3, NELFE and AIF1) are significant genetic targets shared by MetS and multiple rheumatic diseases. This evidence concerns the gene PRRC2A and metabolic syndrome.